MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Repetitive Transcranial Magnetic Stimulation For Freezing Of Gait And Motor Function In Parkinson’s Disease: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials

    J. Pitton Rissardo, A. Fornari Caprara (Camden, USA)

    Objective: To evaluate the effects of repetitive transcranial magnetic stimulation (rTMS) on motor function, freezing of gait (FOG), and mobility in patients with Parkinson’s disease…
  • 2025 International Congress

    Timing And Type Of Adverse Events Following Long-Term Treatment With Levodopa–Entacapone–Carbidopa Intestinal Gel (LECIG) Infusion – Data From The ELEGANCE Interim Analysis

    N. Smith, B. Amlani (Reading, United Kingdom)

    Objective: To evaluate the type and timing of occurrence of treatment-emergent adverse events (AEs) in people with advanced Parkinson’s disease (PD) following up to one…
  • 2025 International Congress

    Alpha-Synuclein Aggregates in the Olfactory Epithelium of Subjects with Parkinson Disease, Dementia, COVID-19, and in Aged Controls

    J. Tomlinson, N. Lengacher, A-K. Jochum, J. Franz, L. Flatz, B. Mollenhauer, C. Stadelmann, J. Woulfe, M. Schlossmacher (Ottawa, Canada)

    Objective: We sought to examine whether neuroepithelial structures of the nasal cavity differ between individuals diagnosed with a Lewy body disorder vs those with COVID19…
  • 2025 International Congress

    Neuroprotective Effects of Thymol in MPTP-Induced Parkinson’s Disease Model in Rats: Molecular Docking, Behavioral, Biochemical, and Histological Investigations

    A. Kumar, V. Malhotra (Ahamdabad, India)

    Objective: This study aimed to investigate the neuroprotective potential of thymol in an MPTP-induced Parkinson’s disease (PD) model in rats, focusing on its ability to…
  • 2025 International Congress

    Botulinium toxin in treatment of Parkinsonism

    A. Wankar (Nagpur, India)

    Objective: This review discusses the use of BT in various motor and non-motor symptoms of Parkinsonism. This review discusses the use of BT in various…
  • 2025 International Congress

    Three-Year Single-Center Experience with Levodopa–Entacapone–Carbidopa Intestinal Gel in Advanced Parkinson’s Disease

    J. Szász, V. Constantin, K. Orbán-Kis, S. Bataga, R. Neagoe, M. Ciorba, K. Kelemen, I. Mihály, S. Szatmári (TARGU MURES, Romania)

    Objective: To evaluate the efficacy of Levodopa-Entacapone-Carbidopa Intestinal Gel (LECIG) in advanced Parkinson’s Disease (APD). Background: LECIG infusion has been available in Romania since 2021.…
  • 2025 International Congress

    Safety Profile of Opicapone in Elderly and Very Elderly Population

    D. Lopes, I. Peixoto, D. Martins, H. Brigas, H. Gama, J. Holenz (Coronado, Portugal)

    Objective: This study aimed to characterize the safety profile of opicapone (OPC) in the elderly and compare post-marketing safety between (A) very elderly patients (≥…
  • 2025 International Congress

    Sustained Motor Symptom Efficacy With Long-Term Levodopa–Entacapone–Carbidopa Intestinal Gel (LECIG) Treatment – Data From The ELEGANCE Interim Analysis

    B. Amlani, N. Smith (Reading, United Kingdom)

    Objective: To evaluate the long-term effect on motor symptoms of advanced Parkinson’s disease (PD) following up to two years of treatment with LECIG by analysis…
  • 2025 International Congress

    Antiparkinson Medication Reduces the Probability of the Multiple Step Saccade Pattern During a Memory-Guided Saccade Task

    M. Munoz, J. Reilly, E. Zou, Y. Rivera, G. Pal, L. Verhagen Metman, L. Goelz, D. Corcos, F. David (Chicago, USA)

    Objective: We wanted to determine how the multiple step saccade pattern responds to antiparkinson medication, as it has been proposed to use this pattern as…
  • 2025 International Congress

    Do Peripheral Inflammatory Markers Predict Impulse Control Disorders in Parkinson’s Disease? Insights from a Retrospective Study

    N. Durmaz Celi̇k, M. Yildiz, S. Ozkan (Eskisehir, Turkey)

    Objective: To evaluate the relationship between hematological inflammatory markers—neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR)—and ICD development in PD patients treated with…
  • « Previous Page
  • 1
  • …
  • 309
  • 310
  • 311
  • 312
  • 313
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley